Pharmaceuticals

Stark Pharma is dedicated to enhancing global healthcare by developing and distributing innovative, high-quality pharmaceutical products. With a robust supply chain and strategic partnerships, we serve both generic and branded markets across various therapeutic areas. Our product portfolio includes formulations in cardiology, oncology, neurology, anti-infectives, and more. Operating in compliance with international regulatory standards such as US FDA, WHO-GMP, and EU-GMP, we ensure the safety, efficacy, and quality of our products.

Therapeutic Categories:

Our diverse product offerings span multiple therapeutic categories:

• Anti-Infectives: Antibiotics, Antivirals
• Cardiovascular Drugs
• Central Nervous System (CNS)
• Gastrointestinal Medicines
• Oncology
• Pain Management
• Respiratory Care
• Dermatology
• Pediatric Formulations
• Nutraceuticals & Supplements

Our Services include:

• End-to-end support in drug development and pre-market submission strategy
• Market intelligence and pipeline planning for formulation and therapeutic focus
• GMP manufacturing partner alignment for technology transfer and scaling
• Dossier compilation (CTD/eCTD) and regulatory submission support for markets including USFDA, EMA, CDSCO, and WHO PQ

Business Engagement Models:

We offer flexible engagement models to meet diverse business needs:

• Contract Manufacturing
• Loan Licensing
• Private Label / White Label
• Licensing & Supply
• Distribution Partnerships

At Stark Pharma, we adopt a forward-looking approach by investing in the future of medicine—across generics, biosimilars, and niche therapeutic solutions. As we continue building partnerships with leading CROs, CMOs, and licensing stakeholders, our goal is to introduce a diverse and accessible portfolio that addresses unmet needs in global healthcare.